Prescribing Paradigm Shift? Damned If You Do, Damned If You Don't

被引：0
作者：
Marx, Nikolaus [1 ]
Grant, Peter J. [2 ]
机构：
[1] Rhein Westfal TH Aachen, Dept Internal Med Cardiol 1, Aachen, Germany
[2] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England
来源：
DIABETES CARE | 2020年 / 43卷 / 09期
关键词：
CARDIOVASCULAR OUTCOMES; EMPAGLIFLOZIN; MORTALITY; DISEASE;
D O I：
10.2337/dci20-0027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1991 / 1993
页数：3
相关论文
共 19 条
  • [1] Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland
    Caparrotta, Thomas M.
    Blackbourn, Luke A. K.
    McGurnaghan, Stuart J.
    Chalmers, John
    Lindsay, Robert
    McCrimmon, Rory
    McKnight, John
    Wild, Sarah
    Petrie, John R.
    Philip, Sam
    McKeigue, Paul M.
    Webb, David J.
    Sattar, Naveed
    Colhoun, Helen M.
    [J]. DIABETES CARE, 2020, 43 (09) : 2034 - 2041
  • [2] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Cosentino, Francesco
    Grant, Peter J.
    Aboyans, Victor
    Bailey, Clifford J.
    Ceriello, Antonio
    Delgado, Victoria
    Federici, Massimo
    Filippatos, Gerasimos
    Grobbee, Diederick E.
    Hansen, Tina Birgitte
    Huikuri, Heikki, V
    Johansson, Isabelle
    Juni, Peter
    Lettino, Maddalena
    Marx, Nikolaus
    Mellbin, Linda G.
    Ostgren, Carl J.
    Rocca, Bianca
    Roffi, Marco
    Sattar, Naveed
    Seferovic, Petar M.
    Sousa-Uva, Miguel
    Valensi, Paul
    Wheeler, David C.
    Piepoli, Massimo Francesco
    Birkeland, Kare, I
    Adamopoulos, Stamatis
    Ajjan, Ramzi
    Avogaro, Angelo
    Baigent, Colin
    Brodmann, Marianne
    Bueno, Hector
    Ceconi, Claudio
    Chioncel, Ovidiu
    Coats, Andrew
    Collet, Jean-Philippe
    Collins, Peter
    Cosyns, Bernard
    Di Mario, Carlo
    Fisher, Miles
    Fitzsimons, Donna
    Halvorsen, Sigrun
    Hansen, Dominique
    Hoes, Arno
    Holt, Richard I. G.
    Home, Philip
    Katus, Hugo A.
    Khunti, Kamlesh
    Komajda, Michel
    Lambrinou, Ekaterini
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (02) : 255 - 323
  • [3] Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
    Gerstein, Hertzel C.
    Colhoun, Helen M.
    Dagenais, Gilles R.
    Diaz, Rafael
    Lakshmanan, Mark
    Pais, Prem
    Probstfield, Jeffrey
    Riesmeyer, Jeffrey S.
    Riddle, Matthew C.
    Ryden, Lars
    Xavier, Denis
    Atisso, Charles Messan
    Dyal, Leanne
    Hall, Stephanie
    Rao-Melacini, Purnima
    Wong, Gloria
    Avezum, Alvaro
    Basile, Jan
    Chung, Namsik
    Conget, Ignacio
    Cushman, William C.
    Franek, Edward
    Hancu, Nicolae
    Hanefeld, Markolf
    Holt, Shaun
    Jansky, Petr
    Keltai, Matyas
    Lanas, Fernando
    Leiter, Lawrence A.
    Lopez-Jaramillo, Patricio
    Cardona Munoz, Ernesto German
    Pirags, Valdis
    Pogosova, Nana
    Raubenheimer, Peter J.
    Shaw, Jonathan E.
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    [J]. LANCET, 2019, 394 (10193) : 121 - 130
  • [4] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    Haffner, SM
    Lehto, S
    Rönnemaa, T
    Pyörälä, K
    Laakso, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) : 229 - 234
  • [5] Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
    Hernandez, Adrian F.
    Green, Jennifer B.
    Janmohamed, Salim
    D'Agostino, Ralph B., Sr.
    Granger, Christopher B.
    Jones, Nigel P.
    Leiter, Lawrence A.
    Rosenberg, Anne E.
    Sigmon, Kristina N.
    Somerville, Matthew C.
    Thorpe, Karl M.
    McMurray, John J. V.
    Del Prato, Stefano
    [J]. LANCET, 2018, 392 (10157) : 1519 - 1529
  • [6] Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
    Holman, Rury R.
    Bethel, M. Angelyn
    Mentz, Robert J.
    Thompson, Vivian P.
    Lokhnygina, Yuliya
    Buse, John B.
    Chan, Juliana C.
    Choi, Jasmine
    Gustavson, Stephanie M.
    Iqbal, Nayyar
    Maggioni, Aldo P.
    Marso, Steven P.
    Ohman, Peter
    Pagidipati, Neha J.
    Poulter, Neil
    Ramachandran, Ambady
    Zinman, Bernard
    Hernandez, Adrian F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13) : 1228 - 1239
  • [7] Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Husain, Mansoor
    Birkenfeld, Andreas L.
    Donsmark, Morten
    Dungan, Kathleen
    Eliaschewitz, Freddy G.
    Franco, Denise R.
    Jeppesen, Ole K.
    Lingvay, Ildiko
    Mosenzon, Ofri
    Pedersen, Sue D.
    Tack, Cees J.
    Thomsen, Mette
    Vilsboll, Tina
    Warren, Mark L.
    Bain, Stephen C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (09) : 841 - 851
  • [8] Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial
    Inzucchi, Silvio E.
    Iliev, Hristo
    Pfarr, Egon
    Zinman, Bernard
    [J]. DIABETES CARE, 2018, 41 (01) : E4 - E5
  • [9] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Marso, Steven P.
    Daniels, Gilbert H.
    Brown-Frandsen, Kirstine
    Kristensen, Peter
    Mann, Johannes F. E.
    Nauck, Michael A.
    Nissen, Steven E.
    Pocock, Stuart
    Poulter, Neil R.
    Ravn, Lasse S.
    Steinberg, William M.
    Stockner, Mette
    Zinman, Bernard
    Bergenstal, Richard M.
    Buse, John B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) : 311 - 322
  • [10] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) : 1995 - 2008
12